&w=3840&q=100)
Here's why Marksans Pharma share price increased over 2% in trade on May 15
However, at 11:20 PM, Marksans Pharma shares pared gains and were trading merely 0.08 per cent higher at ₹238 per share. In comparison, BSE Sensex was trading 0.10 per cent lower at 81,247.08 level.
Why led to the up move in Marksans Pharma share price?
The northward move in Marksans Pharma came after the company's wholly-owned subsidiary, Relonchem, received marketing authorisation for the product Gabapentin 50 mg/ml oral solution from UK Medicines & Healthcare Products Regulatory Agency (UK MHRA).
In an exchange filing, Marksans Pharma said, 'Marksans Pharma hereby announces that its wholly owned subsidiary Relonchem Limited has received marketing authorisation for the product Gabapentin 50 mg/ml oral solution from UK Medicines & Healthcare Products Regulatory Agency.'
Gabapentin is commonly used to treat epilepsy and nerve pain. In epilepsy, it's believed to work by calming abnormal electrical activity in the brain that leads to seizures. It's also effective for managing nerve pain, which may result from conditions such as diabetes, shingles, or physical injuries.
Marksans Pharma results
Marksans Pharma will release its March quarter of financial year 2025 (Q4FY25) results on May 19. The board will also consider recommending a dividend on the equity shares for FY25.
In Q3FY25, Marksans Pharma's operating revenue stood at ₹681.8 crore, up 16.3 per cent year-on-year (Y-o-Y), driven growth across key markets, led by US region
The gross profit stood at ₹383.5 crore, up 22.4 per cent Y-o-Y, with a gross margin expansion of 279 basis points (bps) Y-o-Y to 56.2 per cent. The growth was attributed to softening of raw material prices and a better product mix, the company said in a statement.
About Marksans Pharma
Marksans Pharma, based in Mumbai, specialises in the research, manufacturing, and marketing of generic pharmaceutical formulations in global markets. The company operates manufacturing facilities in India, the USA, and the UK, all of which are approved by regulatory agencies, including the USFDA, UKMHRA, and Australian TGA.
Marksans Pharma offers a diverse product portfolio across key therapeutic areas, such as cardiovascular (CVS), central nervous system (CNS), anti-diabetic, pain management, gastroenterology, and anti-allergies. These products are marketed worldwide.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
Stock markets rally for 4th day; Sensex climbs nearly 371 points on GST reform bid
Benchmark stock indices Sensex and Nifty advanced on Tuesday (August 19, 2025), marking their fourth consecutive day of gains, mainly driven by Reliance Industries and Tata Motors. Rising for the fourth trading day in a row, the 30-share BSE Sensex edged higher by 370.64 points or 0.46% to settle at 81,644.39. During the day, it jumped 482.13 points or 0.59% to 81,755.88. The 50-share NSE Nifty climbed 103.70 points or 0.42% to 24,980.65. Optimism prevailed in the market, buoyed by plans for big bang reforms in the GST regime by Diwali and easing geopolitical worries, analysts said. Among Sensex firms, Tata Motors rose the most by 3.5% while Adani Ports gained 3.16%. Reliance Industries rose by 2.82%. Eternal, Tech Mahindra, Kotak Mahindra Bank, Hindustan Unilever and Maruti were also among the gainers. However, Bajaj Finserv, Power Grid, Mahindra & Mahindra and HCL Tech were among the laggards. 'The national market continued the renewed momentum, buoyed by expectations of GST rationalisation and a recent upgrade in India's credit rating. Additional optimism came from signs of easing geopolitical tensions between Russia and Ukraine, shifting the near-term outlook from consolidation to a more constructive stance,' Vinod Nair, Head of Research, Geojit Investments, said. In Asian markets, South Korea's Kospi, Japan's Nikkei 225 index, Shanghai's SSE Composite and Hong Kong's Hang Seng settled lower. Markets in Europe were trading higher. The U.S. markets ended on a flat note on Monday (August 18, 2025). Global oil benchmark Brent crude declined 0.93% to $65.98 a barrel. Foreign Institutional Investors (FIIs) bought equities worth ₹550.85 crore on Monday (August 18, 2025), according to exchange data. On Monday (August 18, 2025), the Sensex jumped 676.09 points or 0.84% to settle at 81,273.75. The Nifty climbed 245.65 points or 1% to end at 24,876.95.
India.com
an hour ago
- India.com
Mukesh Ambani's shares jump on stock market, Reliance Industries mcap above Rs 19000000000000, Tata Motors shares price climbs by…
On Tuesday , the stock market surged, with both the Sensex and Nifty trading higher. In this positive sentiment, Reliance Industries' share price started the day at Rs 1,390 and quickly climbed to Rs 1,420.60, marking a sharp rise of 2.76%. This rally boosted Reliance's market capitalization to Rs 19.20 lakh crore, shows its dominant position in the market. Why Reliance Industries Shares Trending? Several factors are behind this upward momentum, like positive investor sentiment driven by the growth potential of the company's telecom and FMCG divisions. Reliance Jio has made a strategic move by raising its tariffs and discontinuing its entry-level plan which will make customers opt for higher value options. At the same time Reliance Consumer Products Ltd. (RCPL) has entered the healthy beverage segment through a joint venture with Naturedge Beverages, another move contributing to renewed investor enthusiasm. How Reliance Industries And Tata Motors Led Rally In Stock Market? Benchmark stock indices Sensex and Nifty advanced on Tuesday, marking their fourth consecutive day of gains, mainly driven by Reliance Industries and Tata Motors. Rising for the fourth trading day in a row, the 30-share BSE Sensex edged higher by 370.64 points or 0.46 per cent to settle at 81,644.39. During the day, it jumped 482.13 points or 0.59 per cent to 81,755.88. The 50-share NSE Nifty climbed 103.70 points or 0.42 per cent to 24,980.65. Among Sensex firms, Tata Motors rose the most by 3.5 per cent while Adani Ports gained 3.16 per cent. Reliance Industries rose by 2.82 per cent. Eternal, Tech Mahindra, Kotak Mahindra Bank, Hindustan Unilever and Maruti were also among the gainers. (With Inputs From PTI)
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
BSE IPO index rallies 2%; Denta Water, Belrise, Hyundai Motor hit new highs
BSE IPO index rallied 2 per cent on the BSE in Tuesday's intra-day trade after a sharp surge in the recently listed companies. Denta Water and Infra Solutions, Belrise Industries, Hyundai Motor India, Brigade Hotel Ventures, JSW Cement and Smartworks Coworking Spaces have hit their respective new highs. These stocks have rallied in the range of 5 per cent to 16 per cent in intra-day trade today. At 02:26 PM, the BSE IPO index was up 1.6 per cent, as compared to a 0.42 per cent rise in the BSE Sensex. In the past week, the IPO index gained 3.5 per cent, as against a 0.83 per cent rise in the benchmark index. Why are newly listed stocks rising? Among the individual stocks, Denta Water and Infra Solutions have zoomed 16 per cent to ₹397 on the back of a six-fold jump in average trading volumes. A combined 8.05 million shares representing 30 per cent of the total equity of the company have changed hands on the NSE and BSE. Denta Water is a leading civil engineering contractor in the water infrastructure sector. The company has also selectively expanded into allied sectors such as railways and highways, in line with its long-term diversification and growth strategy. As of June 30, 2025, the company have an order book of ₹593.7 crore, providing multi-year revenue visibility. Shares of Belrise Industries have rallied 12 per cent to ₹156.25 on the back of heavy volumes. As many as 55.69 million shares representing 6.3 per cent of the total equity of the auto ancillary company have changed hands on the NSE and BSE. Currently, the stock is trading 74 per cent higher over its issue price of ₹90 per share. The company made its stock market debut on May 28, 2025. Shares of Hyundai Motor India hit a new high of ₹2,549, as they rallied 5 per cent in intra-day trade. In the past two trading days, the stock price of India's second-largest player in Passenger Vehicle (PV) has surged 14 per cent after the Prime Minister of India, in his Independence Day address, announced "next generation GST reforms", which will be rolled out by Diwali 2025. Currently, Hyundai Motor India is trading 30 per cent higher over its issue price of ₹1,960 per share. The company made its stock market debut on October 22, 2024. The stock has bounced back 65 per cent from its 52-week low of ₹1,542.95 touched on April 7, 2025. The government has proposed GST 2.0 reform, which aims to rationalise the current multi-slab structure into a simpler framework, with two main rates of 5 per cent and 18 per cent, and a higher 40 per cent slab for luxury and sin goods. If the base GST rate of 28 per cent gets revised to 18 per cent, this is positive for the entire sector (including the auto component supply chain) and is expected to drive demand across all segments (PV, 2-W, 3-W & CV). This shall lower the initial purchase price of vehicles for consumers in the range of ~5-10 per cent, according to analysts at ICICI Securities. Shares of Brigade Hotel Ventures have gained 7 per cent to ₹91.74 on the back of a five-fold jump in trading volumes. The stock has recovered 18 per cent from its recent low of ₹77.45 touched on August 6, 2025. The company made its stock market debut on July 31, 2025. Currently, the stock is trading 2 per cent above its issue price of ₹90.
